首页> 外文OA文献 >PRS58 Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access

【2h】

PRS58 Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access

机译：PRS58伴随诊断生物标志物作为个性化药品市场准入的看门人的健康技术评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Spinner D.S.; Ransom J.F.; Culp J.L.; Chawla A.S.; Doyle J.J.; Faulkner E.C.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics [J] . Tsourounis Marilyn, Stuart Jeffrey, Pignato William, Therapeutic innovation & regulatory science. . 2015,第4期

机译：个性化医学和伴侣诊断的当前趋势：DIA关于个性化医学和伴侣诊断的会议摘要
2. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics. [J] . David R Parkinson, Bruce E Johnson, George W Sledge Clinical cancer research: an official journal of the American Association for Cancer Research . 2012,第3期

机译：使个性化的癌症医学成为现实：生物标志物和伴随诊断技术开发中的挑战和机遇。
3. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics. [J] . David R Parkinson, Bruce E Johnson, George W Sledge Clinical cancer research: an official journal of the American Association for Cancer Research . 2012,第3期

机译：使个性化的癌症医学成为现实：生物标志物和伴随诊断技术开发中的挑战和机遇。
4. Large-scale metabolomics lipidomics to discover biomarkers of healthy aging and personalizing medicine [C] . Thomas Hankemeier International Mass Spectrometry Conference . 2014

机译：大规模的代谢组合和脂类动物，发现健康老化和个性化的生物标志物
5. Gene-Chip Diagnostics for Personalized Global Medicine [D] . Hwang, Michael Taeyoung. 2017

机译：个性化全球医学的基因芯片诊断
6. Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine [O] . Federica Sotgia, Michael P. Lisanti 2017

机译：线粒体生物标志物预测胃癌的肿瘤进展和总体存活率低：个性化药物的伴随诊断
7. PCN215 Next Generation Sequencing Technology: Health Technology Assessment, Market Access Trends and Potential Impacts on The Future of Companion Diagnostic Testing [O] . Faulkner E.C., Spinner D.S., Ransom J.F., 2014

机译：PCN215下一代测序技术：健康技术评估，市场准入趋势以及对伴侣诊断测试未来的潜在影响

PRS58 Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access

著录项

引文网络

相似文献

相关主题

期刊订阅